Figs Inc vs Health Care Select Sector SPDR Fund — how do they compare? Figs Inc trades at $15.29 (market cap $2.49B), while Health Care Select Sector SPDR Fund trades at $170.32 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 17.5× Figs Inc's market cap, and Health Care Select Sector SPDR Fund is more actively traded (11,121,431 versus 5,964,311). Which is the better fit depends on your goals — on Pluang, investors hold Figs Inc for 33 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| FIGS | XLV | |
|---|---|---|
Market Cap | $2.49B | $43.48B |
Volume | 5,964,311 | 11,121,431 |
Sector | Consumer Cyclical | — |
52-Week High | $17.12 | $175.68 |
52-Week Low | $6.90 | $141.95 |
Typical Hold Time | 33 Days | 100 Days |
Enterprise Value | $2.25B | — |
Signals from Pluang's Aura AI — not financial advice
FIGS trades at $14.06, down 0.28% on the day, with a bullish technical signal supported by moving averages. The company shows strong revenue growth with 2025 revenue reaching $631.10M and net income of $34.25M, representing a 5.42% margin. Recent earnings beats and raised 2026 guidance indicate positive momentum, though valuation ratios remain elevated with a P/E of 45.39 and P/S of 4.02.
Wall Street maintains a bullish stance with 60% buy ratings and a $18.00 consensus price target, suggesting 28% upside potential. Key risks include execution challenges in international expansion and rich valuation multiples that require continued strong performance. The company's expanding customer base and international growth provide catalysts for future appreciation.
XLV trades at $169.58 with a slight 0.46% daily gain amid bearish technical signals. The ETF faces selling pressure with moving averages indicating downward momentum while oscillators remain neutral. Recent news highlights XLV's competitive expense ratio of 0.08% and defensive healthcare sector positioning. Options activity shows increased put volume, suggesting some investor caution despite the fund's diversification across 61 healthcare stocks.
The healthcare ETF presents a cost-effective defensive play with potential upside if political volatility subsides post-elections. Key risks include sector-specific regulatory pressures and biotech trial failures impacting holdings. Current technical weakness near support at $166 requires monitoring for potential breakdown, though the fund's low fees and broad diversification provide stability during market uncertainty.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →